Connection

Besim Ogretmen to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Besim Ogretmen has written about Protein Kinase Inhibitors.
Besim Ogretmen
Connection Strength
0.222
Protein Kinase Inhibitors
  1. Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Nat Commun. 2019 03 21; 10(1):1296.
    View in: PubMed
    Score: 0.132
  2. PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest. 2013 Oct; 123(10):4144-57.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.